Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 2
2017 4
2018 2
2019 3
2020 2
2021 3
Text availability
Article attribute
Article type
Publication date

Search Results

16 results
Results by year
Filters applied: . Clear all
Page 1
The future of oncology therapeutics.
Mansinho A, Boni V, de Miguel M, Calvo E. Mansinho A, et al. Expert Rev Anticancer Ther. 2017 Jul;17(7):563-565. doi: 10.1080/14737140.2017.1331131. Epub 2017 May 22. Expert Rev Anticancer Ther. 2017. PMID: 28504011 No abstract available.
Bone metastasis risk factors in breast cancer.
Pulido C, Vendrell I, Ferreira AR, Casimiro S, Mansinho A, Alho I, Costa L. Pulido C, et al. Among authors: mansinho a. Ecancermedicalscience. 2017 Jan 24;11:715. doi: 10.3332/ecancer.2017.715. eCollection 2017. Ecancermedicalscience. 2017. PMID: 28194227 Free PMC article. Review.
Prognostic factors for patients treated with abiraterone.
Alvim CM, Mansinho A, Paiva RS, Brás R, Semedo PM, Lobo-Martins S, da Ponte CB, Macedo D, Ribeiro L, Dos Reis JP, Fernandes I, Costa L. Alvim CM, et al. Among authors: mansinho a. Future Sci OA. 2019 Dec 12;6(2):FSO436. doi: 10.2144/fsoa-2019-0079. Future Sci OA. 2019. PMID: 32025327 Free PMC article.
Expression of receptor activator of NFkB (RANK) drives stemness and resistance to therapy in ER+HER2- breast cancer.
Gomes I, de Almeida BP, Dâmaso S, Mansinho A, Correia I, Henriques S, Cruz-Duarte R, Vilhais G, Félix P, Alves P, Corredeira P, Barbosa-Morais NL, Costa L, Casimiro S. Gomes I, et al. Among authors: mansinho a. Oncotarget. 2020 May 12;11(19):1714-1728. doi: 10.18632/oncotarget.27576. eCollection 2020 May 12. Oncotarget. 2020. PMID: 32477461 Free PMC article.
16 results